Detección de la hipertensión arterial pulmonar en esclerosis sistémica basada en la evidencia: Estudio DETECT

Detección de la hipertensión arterial pulmonar en esclerosis sistémica basada en la evidencia: Estudio DETECT

Contenido principal del artículo

Pablo Ramón Gil Torres, MD
Claudio Villaquirán Torres, MD

Detalles del artículo

Biografía del autor/a (VER)

Pablo Ramón Gil Torres, MD, Universidad ICESI

Residente de tercer año de Medicina Interna, Universidad ICESI, Fundación Valle del Lili, Cali, Colombia.

Claudio Villaquirán Torres, MD, Pontificia Universidad Javeriana

Internista, Neumólogo, Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogotá, Colombia.

Referencias (VER)

Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis

Rheum. 2005;52:3792–800.

Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum

Dis. 2003;62:1088–93.

Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary

Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J.

;30:2493–537.

Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology. 2004;43:461-6.

Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011;63:3522–30.

Galiè N, Rubin Lj, Hoeper M, Jansa P, Al-Hiti H, Meyer G. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind randomized controlled trial. Lancet. 2008;371:2093–100.

Citado por